TrialCardiovascular diabetology2024

Pentoxifylline ameliorates subclinical atherosclerosis progression in patients with type 2 diabetes and chronic kidney disease: a randomized pilot trial.

Javier Donate-Correa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.